Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amylyx, Beam, Maat, Pheast, Sanofi, Spinogenix, Teijin, Tenpoint.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ascendis, GSK, Immunitybio, Kura, Kyowa Kirin, Mabwell, Moderna, Zealand.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Accuredit, Bio-Thera, Carsgen, Eisai, Experimental Drug Development Centre, Henlius, Jiangsu Hengrui, Junshi, Otsuka, Remegen, Samsung Bioepis, Teva.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Clarity, Hyperfine.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beam, Zymeworks.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Iradimed, Reflow Medical.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Accuredit, Alcon, Bayer, Capsida, Daiichi, Eton, Jiangsu Hengrui, Merck, Stealth.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: BMS, Candel, Carsgen, Eisai, Halozyme, Mitsubishi, Teva.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Anx Robotica, Distalmotion, Empatia, Hyperfine, Olympus.
RSS